Bristol-Myers Squibb Company
Combination Therapy for Melanoma
Last updated:
Abstract:
The invention provides a method of treating a previously untreated metastatic or unresectable melanoma.
Status:
Application
Type:
Utility
Filling date:
18 Oct 2019
Issue date:
4 Nov 2021